PREPAIRE LABS LIMITED – Trademark Portfolio
Entity Type: 16
PREPAIRE LABS LIMITED holds 7 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 9 (Computers & Electronics) — 4 filings in this category. The portfolio also extends into Class 5 (Pharmaceuticals) across 3 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include PREPAIRE SHIELD. The owner is based in LOUGHLINSTOWN.
UNIT 11, BLD. 10
CHERRYWOOD BUSINESS PK
LOUGHLINSTOWN D18T3Y1 , IE
Showing of trademarks Trademarks
Trademark Classifications
PREPAIRE LABS LIMITED's trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Scientific and technological services; industrial analysis and research services
Frequently Asked Questions
How many trademarks does PREPAIRE LABS LIMITED have?
PREPAIRE LABS LIMITED has 7 U.S. trademarks filed with the USPTO. Of these, 1 registered, 6 abandoned.
What trademark classes does PREPAIRE LABS LIMITED file in?
PREPAIRE LABS LIMITED files trademarks across 3 Nice Classification classes. The most active classes are Class 9 (Computers & Electronics), Class 5 (Pharmaceuticals), Class 42 (Computer & Scientific). Class 9 covers scientific, nautical, surveying, photographic, cinematographic, optical apparatus and instruments.
What are PREPAIRE LABS LIMITED's most well-known trademarks?
PREPAIRE LABS LIMITED's registered trademark portfolio includes well-known marks such as PREPAIRE SHIELD. These are among 1 currently registered trademark in the portfolio.
What is PREPAIRE LABS LIMITED's trademark registration success rate?
PREPAIRE LABS LIMITED has a 14% trademark registration rate, with 1 out of 7 resolved applications resulting in successful registration. Currently, 0 applications are pending review.